| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals, Inc. | Director | Common Stock | 10.9 M | $73.4 M | $6.74 | Jun 17, 2021 | Indirect |
| Kala Pharmaceuticals, Inc. | Director | Common Stock | 20 K | $135 K | $6.74 | Jun 17, 2021 | Direct |
| Solid Biosciences Inc. | Director, 10%+ Owner | Director Stock Option (Right to Buy) | 30 K | Jun 16, 2021 | Direct | ||
| Black Diamond Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16.5 K | May 16, 2023 | Indirect | ||
| Satsuma Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock, $0.0001 par value | 0 | $0.91 | Jun 6, 2023 | Indirect | |
| Satsuma Pharmaceuticals, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 0 | Jun 8, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| STSA | Satsuma Pharmaceuticals, Inc. | Jun 6, 2023 | 4 | -$5.38 M | 4 | Jun 8, 2023 | Director, 10%+ Owner |
| BDTX | Black Diamond Therapeutics, Inc. | May 16, 2023 | 1 | $0 | 4 | May 17, 2023 | Director |
| BDTX | Black Diamond Therapeutics, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| BDTX | Black Diamond Therapeutics, Inc. | Jun 18, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
| KALA | Kala Pharmaceuticals, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
| SLDB | Solid Biosciences Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director, 10%+ Owner |
| BDTX | Black Diamond Therapeutics, Inc. | May 20, 2021 | 1 | -$10.6 K | 4 | May 21, 2021 | Director |